ArticleFrontiers in oncology2026

Exceptional response to everolimus in an NF1-deficient recurrent endometrioid adenocarcinoma: a case report.

Maja Machulak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.